Literature DB >> 28228703

Pathway Oriented Therapy in Breast Cancer - a Light at the End of the Tunnel!

Eugen Ruckhäberle1, Tanja Fehm1.   

Abstract

Entities:  

Year:  2016        PMID： 28228703      PMCID： PMC5290442          DOI： 10.1159/000454659

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  8 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Authors:  A S Coates; E P Winer; A Goldhirsch; R D Gelber; M Gnant; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2015-05-04       Impact factor: 32.976

Review 3.  HER2-Orientated Therapy in Early and Metastatic Breast Cancer.

Authors:  Severine Iborra; Elmar Stickeler
Journal:  Breast Care (Basel)       Date:  2016-12-08       Impact factor: 2.860

Review 4.  The PI3K Pathway: Background and Treatment Approaches.

Authors:  Michael P Lux; Peter A Fasching; Michael G Schrauder; Alexander Hein; Sebastian M Jud; Claudia Rauh; Matthias W Beckmann
Journal:  Breast Care (Basel)       Date:  2016-12-08       Impact factor: 2.860

Review 5.  PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer.

Authors:  Andreas D Hartkopf; Florin-Andrei Taran; Markus Wallwiener; Christina B Walter; Bernhard Krämer; Eva-Maria Grischke; Sara Y Brucker
Journal:  Breast Care (Basel)       Date:  2016-12-08       Impact factor: 2.860

6.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

7.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.